Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-030872
Filing Date
2022-11-08
Accepted
2022-11-08 06:11:36
Documents
2
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 89511
2 ex24-1.htm EX-24.1 11236
  Complete submission text file 0001493152-22-030872.txt   102157
Mailing Address C/O HEALTHWORLD CORP 100 AVENUE OF THE AMERICAS NEW YORK NY 10013
Business Address
GIRGENTI STEVEN (Reporting) CIK: 0001055530 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41463 | Film No.: 221367104

Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Issuer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research